Carrisann Tennessee Woods, D.O. Obstetrics & Gynecology - Obstetrics Medicare: Accepting Medicare Assignments Practice Location: 525 Branson Landing Blvd Ste 408, Branson, MO 65616 Phone: 417-335-7295 Fax: 417-335-7230 |
Dr. Richard Douglas Stiff, M.D. Obstetrics & Gynecology - Gynecology Medicare: Medicare Enrolled Practice Location: 2335 State Highway 265, Suite 200, Branson, MO 65616 Phone: 417-942-2873 |
Dr. John L Mccarville Jr., DO Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 525 Branson Landing Blvd Ste 408, Branson, MO 65616 Phone: 417-348-8313 Fax: 417-335-7230 |
Charles Albritton, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 525 Branson Landing Blvd Ste 408, Branson, MO 65616 Phone: 417-348-8313 Fax: 417-335-7230 |
News Archive
When we turn on the A/C in the summer, our first thought is probably one of relief. If it's 100 degrees in the shade, we're probably not thinking about how our decision might influence the environmental legacy we leave for future generations. It's not that we don't care, it's just that we typically don't think about our behavior in terms of long-term, inter-generational tradeoffs. But new research suggests that reminders of our own mortality may encourage us to keep future generations in mind as we make decisions.
In Florida, a federal court judge heard oral arguments surrounding the 20-state challenge to the health overhaul. At issue are two key elements of the new law: its mandate requiring that almost everyone have health insurance and its expansions of the Medicaid program. Although the judge said his ruling would take some time, he did offer some signals about the direction he might take.
The Boston Globe reports on the dramatic and fearful response to a "seemingly prosaic piece" of pending Massachusetts state legislation "that aims to better define - and, in some respects, restrict - the emergency powers of the state's public health officials."
The monoclonal antibody nivolumab achieves superior response rates and a longer duration of response than standard chemotherapy in patients whose melanoma has progressed after treatment with ipilimumab, according to phase III data presented at the ESMO 2014 Congress in Madrid, Spain.
› Verified 3 days ago